SCHEMBL19110600

SCHEMBL19110600

Cc1ccc(Cn2nc(C)c3c2CNCC3)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 2/20 0.43
HTR2A P28223 2/20 0.41
HTR1A P08908 1/20 0.41
CXCR4 P61073 1/20 0.40
HTR2C P28335 5/20 0.38
HTR2B P41595 4/20 0.38
HTR6 P50406 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GAA P10253 2/20 0.36
LMNA P02545 1/20 0.36
NPC1 O15118 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19110587 0.90 HTR7 (0.53) HTR7HTR2AHTR1AHTR2CHTR2B
SCHEMBL19110586 0.89 SLC2A1 (0.48) HTR7
SCHEMBL19110591 0.89 HTR7 (0.54) HTR7HTR2AHTR1AHTR2CHTR2B
SCHEMBL17317536 0.83 GRIA2 (0.46) HTR7HTR2AHTR1AHTR2CHTR2B
Hydrochloric Acid SCHEMBL19097267 0.82 GRIA2 (0.46) HTR7HTR2AHTR1AHTR2CHTR2B
SCHEMBL19110601 0.81 ALDH1A1 (0.42) HTR7HTR2AHTR1AHTR2CHTR2B
SCHEMBL19110655 0.80 HTR7 (0.43) HTR7HTR2AHTR1AHTR2CHTR2B
SCHEMBL19110604 0.77 HTR7 (0.33) HTR7HTR2AHTR1AHTR2CHTR2B
SCHEMBL19110605 0.77 LMNA (0.45) HTR7HTR2AHTR1AHTR2CHTR2B
SCHEMBL19110602 0.76 CYP1A2 (0.40) HTR7HTR2AHTR1AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170197960-A1 ATX MODULATING AGENTS BIOGEN MA INC. 2017-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170197960-A1 ATX MODULATING AGENTS ENPP2, ATXN10, ATXN2 HTR7 755/4885HTR2A 168/4885HTR1A 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.